Add to Calendar WCM-Q Grand Rounds 1/10/2021 3:30:00 PM 1/10/2021 4:30:00 PM Asia/Riyadh Livestream (Zoom) false MM/DD/YYYY


Date & Location
Occurs every 2 weeks on Sunday starting on 1/10/2021 at 3:30 PM
Sunday, January 10, 2021, 3:30 PM - 4:30 PM, Livestream (Zoom), Doha, Qatar

Overview
WCM-Q Grand Rounds is a lecture series with the aim of providing physicians and other healthcare practitioners updates on current issues related to healthcare. Grand Rounds have been long an integral part of the education of physicians and this series will be delivered in a format that promotes presenter/audience interactions. The series will not focus on any one area speciality but offer an array of multidisciplinary topics. WCM-Q Grand Rounds will be held twice per month. Each lecture will be maximum of one hour in length , including 15 mins for a question and answer period. Participants will benefit from the opportunity to discuss topics that can help in the improvement of patient care.

Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Students


Objectives
  1. 1- Identify key factors and challenges in addressing a variety of health needs generally and also apply them to the local cultural expectations
  2. 2- Discuss the impact this expanded knowledge has on their ability to diagnose or assess the patient
  3. 3- Identify the benefits the gained knowledge has on developing a multidisciplinary approach to patient care

Registration
No Registration Fee

Accreditation

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions (DHP) of the Ministry of Public Health.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1 hour. 

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Aicha Hind Rifai, MD, Thurayya Arayssi, MD, Sohaila Cheema, MBBS, Deema Al-Sheikhly, MRes, MEPH, Sheila Qureshi, PhD, Christopher Triggle, PhD, Maria Paiva, PharmD, Andrew Jones, BSN, Phyllis Sui Muffuh Navti, Doctorate in Pharmacy Practice, Reshma Bholah, MD, Constatina Dalassou, DDS, Devin Thompson, RT have no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Faculty: Khalid Alyafei, MD, Laurence Guttmacher, MD, Anas Hamad, PhD, Takeshi Iwatsubo, MD, Moune Jabre, MD, Marcus Lance, MD, Patrick Tang, MD, Maria Janjua, MD, Ross MacDonald, PhD, Sinead O'Rourke, MSc, Ali Elbeddini, PharmD, Ahmed Awaisu, PhD, BPharm, Nigel Pereira, MD have no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Faculty: Jamie Gray, MLS, MS, has disclosed the following: Stock Shareholder (excluding mutual funds) – Allergen; Proctor & Gamble; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Administrative Contact: Safia Rabia has disclosed the following: Spouse, employee – Al-Wehda Medical Group; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

ICR: Aicha Hind Rifai, MD, has no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.